tiprankstipranks
Trending News
More News >
Biora Therapeutics (BIORQ)
OTHER OTC:BIORQ
US Market

Biora Therapeutics (BIORQ) Ratios

Compare
1,088 Followers

Biora Therapeutics Ratios

BIORQ's free cash flow for Q3 2024 was $1.00. For the 2024 fiscal year, BIORQ's free cash flow was decreased by $ and operating cash flow was $-632.69. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
0.30
Quick Ratio
0.30
Cash Ratio
0.24
Solvency Ratio
-0.93
Operating Cash Flow Ratio
-0.77
Short-Term Operating Cash Flow Coverage
-24.54
Net Current Asset Value
$ -113.56M$ ―$ ―$ ―$ ―
Leverage Ratios
Debt-to-Assets Ratio
1.52
Debt-to-Equity Ratio
-0.47
Debt-to-Capital Ratio
-0.88
Long-Term Debt-to-Capital Ratio
-0.76
Financial Leverage Ratio
-0.31
Debt Service Coverage Ratio
-9.67
Interest Coverage Ratio
-6.84
Debt to Market Cap
9.14M
Interest Debt Per Share
36.29
Net Debt to EBITDA
-0.28
Profitability Margins
Gross Profit Margin
100.00%
EBIT Margin
-2865225.00%
EBITDA Margin
-2851350.00%
Operating Profit Margin
-1678575.00%
Pretax Profit Margin
-3110600.00%
Net Profit Margin
-3102875.00%
Continuous Operations Profit Margin
-3108350.00%
Net Income Per EBT
99.75%
EBT Per EBIT
185.31%
Return on Assets (ROA)
-397.61%
Return on Equity (ROE)
121.86%
Return on Capital Employed (ROCE)
211.43%
Return on Invested Capital (ROIC)
232.28%
Return on Tangible Assets
-493.64%
Earnings Yield
-7868681803.23%
Efficiency Ratios
Receivables Turnover
<0.01
Payables Turnover
0.00
Inventory Turnover
0.00
Fixed Asset Turnover
<0.01
Asset Turnover
<0.01
Working Capital Turnover Ratio
>-0.01
Cash Conversion Cycle
75.74K
Days of Sales Outstanding
75.74K
Days of Inventory Outstanding
0.00
Days of Payables Outstanding
0.00
Operating Cycle
75.74K
Cash Flow Ratios
Operating Cash Flow Per Share
-30.75
Free Cash Flow Per Share
-30.81
CapEx Per Share
0.07
Free Cash Flow to Operating Cash Flow
1.00
Dividend Paid and CapEx Coverage Ratio
-470.86
Capital Expenditure Coverage Ratio
-470.86
Operating Cash Flow Coverage Ratio
-1.02
Operating Cash Flow to Sales Ratio
-12.12K
Free Cash Flow Yield
-972040000.00%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01
Price-to-Sales (P/S) Ratio
<0.01
Price-to-Book (P/B) Ratio
>-0.01
Price-to-Free Cash Flow (P/FCF) Ratio
>-0.01
Price-to-Operating Cash Flow Ratio
>-0.01
Price-to-Earnings Growth (PEG) Ratio
<0.01
Price-to-Fair Value
>-0.01
Enterprise Value Multiple
-0.28
Enterprise Value
32.22M
EV to EBITDA
-0.28
EV to Sales
8.05K
EV to Free Cash Flow
-0.66
EV to Operating Cash Flow
-0.66
Tangible Book Value Per Share
-68.15
Shareholders’ Equity Per Share
-64.30
Tax and Other Ratios
Effective Tax Rate
<0.01
Revenue Per Share
<0.01
Net Income Per Share
-78.69
Tax Burden
1.00
Interest Burden
1.09
Research & Development to Revenue
7.46K
SG&A to Revenue
0.00
Stock-Based Compensation to Revenue
4.12K
Income Quality
0.39
Currency in USD